Evaluation of peritoneal microbubble oxygenation therapy in a rabbit model of hypoxemia

Nathan D. Legband, Jameel A. Feshitan, Mark A. Borden, Benjamin S. Terry

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Alternative extrapulmonary oxygenation technologies are needed to treat patients suffering from severe hypoxemia refractory to mechanical ventilation. We previously demonstrated that peritoneal microbubble oxygenation (PMO), in which phospholipid-coated oxygen microbubbles (OMBs) are delivered into the peritoneal cavity, can successfully oxygenate rats suffering from a right pneumothorax. This study addressed the need to scale up the procedure to a larger animal with a splanchnic cardiac output similar to humans. Our results show that PMO therapy can double the survival time of rabbits experiencing complete tracheal occlusion from 6.6 \pm 0.6 min for the saline controls to 12.2 \pm 3.0 min for the bolus PMO-treated cohort. Additionally, we designed and tested a new peritoneal delivery system to circulate OMBs through the peritoneal cavity. Circulation achieved a similar survival benefit to bolus delivery under these conditions. Overall, these results support the feasibility of the PMO technology to provide extrapulmonary ventilation for rescue of severely hypoxic patients.

Original languageEnglish (US)
Article number7001576
Pages (from-to)1376-1382
Number of pages7
JournalIEEE Transactions on Biomedical Engineering
Volume62
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Oxygenation
Oxygen
Phospholipids
Refractory materials
Ventilation
Rats
Animals

Keywords

  • acute lung injury (ALI)
  • acute respiratory distress syndrome (ARDS)
  • airway obstruction
  • extrapulmonary ventilation
  • oxygen delivery

ASJC Scopus subject areas

  • Biomedical Engineering

Cite this

Evaluation of peritoneal microbubble oxygenation therapy in a rabbit model of hypoxemia. / Legband, Nathan D.; Feshitan, Jameel A.; Borden, Mark A.; Terry, Benjamin S.

In: IEEE Transactions on Biomedical Engineering, Vol. 62, No. 5, 7001576, 01.05.2015, p. 1376-1382.

Research output: Contribution to journalArticle

Legband, Nathan D. ; Feshitan, Jameel A. ; Borden, Mark A. ; Terry, Benjamin S. / Evaluation of peritoneal microbubble oxygenation therapy in a rabbit model of hypoxemia. In: IEEE Transactions on Biomedical Engineering. 2015 ; Vol. 62, No. 5. pp. 1376-1382.
@article{854300ab7f194d20a29147c1ed790c86,
title = "Evaluation of peritoneal microbubble oxygenation therapy in a rabbit model of hypoxemia",
abstract = "Alternative extrapulmonary oxygenation technologies are needed to treat patients suffering from severe hypoxemia refractory to mechanical ventilation. We previously demonstrated that peritoneal microbubble oxygenation (PMO), in which phospholipid-coated oxygen microbubbles (OMBs) are delivered into the peritoneal cavity, can successfully oxygenate rats suffering from a right pneumothorax. This study addressed the need to scale up the procedure to a larger animal with a splanchnic cardiac output similar to humans. Our results show that PMO therapy can double the survival time of rabbits experiencing complete tracheal occlusion from 6.6 \pm 0.6 min for the saline controls to 12.2 \pm 3.0 min for the bolus PMO-treated cohort. Additionally, we designed and tested a new peritoneal delivery system to circulate OMBs through the peritoneal cavity. Circulation achieved a similar survival benefit to bolus delivery under these conditions. Overall, these results support the feasibility of the PMO technology to provide extrapulmonary ventilation for rescue of severely hypoxic patients.",
keywords = "acute lung injury (ALI), acute respiratory distress syndrome (ARDS), airway obstruction, extrapulmonary ventilation, oxygen delivery",
author = "Legband, {Nathan D.} and Feshitan, {Jameel A.} and Borden, {Mark A.} and Terry, {Benjamin S.}",
year = "2015",
month = "5",
day = "1",
doi = "10.1109/TBME.2015.2388611",
language = "English (US)",
volume = "62",
pages = "1376--1382",
journal = "IEEE Transactions on Biomedical Engineering",
issn = "0018-9294",
publisher = "IEEE Computer Society",
number = "5",

}

TY - JOUR

T1 - Evaluation of peritoneal microbubble oxygenation therapy in a rabbit model of hypoxemia

AU - Legband, Nathan D.

AU - Feshitan, Jameel A.

AU - Borden, Mark A.

AU - Terry, Benjamin S.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Alternative extrapulmonary oxygenation technologies are needed to treat patients suffering from severe hypoxemia refractory to mechanical ventilation. We previously demonstrated that peritoneal microbubble oxygenation (PMO), in which phospholipid-coated oxygen microbubbles (OMBs) are delivered into the peritoneal cavity, can successfully oxygenate rats suffering from a right pneumothorax. This study addressed the need to scale up the procedure to a larger animal with a splanchnic cardiac output similar to humans. Our results show that PMO therapy can double the survival time of rabbits experiencing complete tracheal occlusion from 6.6 \pm 0.6 min for the saline controls to 12.2 \pm 3.0 min for the bolus PMO-treated cohort. Additionally, we designed and tested a new peritoneal delivery system to circulate OMBs through the peritoneal cavity. Circulation achieved a similar survival benefit to bolus delivery under these conditions. Overall, these results support the feasibility of the PMO technology to provide extrapulmonary ventilation for rescue of severely hypoxic patients.

AB - Alternative extrapulmonary oxygenation technologies are needed to treat patients suffering from severe hypoxemia refractory to mechanical ventilation. We previously demonstrated that peritoneal microbubble oxygenation (PMO), in which phospholipid-coated oxygen microbubbles (OMBs) are delivered into the peritoneal cavity, can successfully oxygenate rats suffering from a right pneumothorax. This study addressed the need to scale up the procedure to a larger animal with a splanchnic cardiac output similar to humans. Our results show that PMO therapy can double the survival time of rabbits experiencing complete tracheal occlusion from 6.6 \pm 0.6 min for the saline controls to 12.2 \pm 3.0 min for the bolus PMO-treated cohort. Additionally, we designed and tested a new peritoneal delivery system to circulate OMBs through the peritoneal cavity. Circulation achieved a similar survival benefit to bolus delivery under these conditions. Overall, these results support the feasibility of the PMO technology to provide extrapulmonary ventilation for rescue of severely hypoxic patients.

KW - acute lung injury (ALI)

KW - acute respiratory distress syndrome (ARDS)

KW - airway obstruction

KW - extrapulmonary ventilation

KW - oxygen delivery

UR - http://www.scopus.com/inward/record.url?scp=84928718337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928718337&partnerID=8YFLogxK

U2 - 10.1109/TBME.2015.2388611

DO - 10.1109/TBME.2015.2388611

M3 - Article

C2 - 25576562

AN - SCOPUS:84928718337

VL - 62

SP - 1376

EP - 1382

JO - IEEE Transactions on Biomedical Engineering

JF - IEEE Transactions on Biomedical Engineering

SN - 0018-9294

IS - 5

M1 - 7001576

ER -